Investigating the Roles of Gut Microbiome in the Progression of Neurodegenerative Diseases: Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis (ALS)
Emmanson Emmanson Godswill, Ogunwale Fawas Abiodun, Chiamaka Mercy Ogboji, Ojo Oluwakemi Janet, Anthonia. B. O, Sunday Kaura, Augustine Chibuike Olunwa, Godswill Obidike
International Neuropsychiatric Disease Journal · pp. 26–44 · Published 6 Apr 2024
10.9734/indj/2024/v21i3433Abstract
Neurodegenerative diseases (NDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Amyotrophic Lateral Sclerosis (ALS), pose global health burdens due to their incurable and degenerative nature. Emerging evidence highlights the complex interplay between the gut microbiome and the central nervous system (CNS), revealing novel mechanisms of ND pathogenesis and progression. This review integrates current literature, correlation analyses, and inferential statistics to elucidate the impact of gut microbiome dysbiosis on NDs and identify potential diagnostic biomarkers and therapeutic targets. The gut-brain axis (GBA), a bidirectional communication network between the gut and the brain, modulates neurological function and disease outcomes. Correlation analyses demonstrated significant associations between gut microbiome perturbations and ND parameters, implying a causal role for gut dysbiosis in ND pathogenesis. Inferential statistics revealed distinct microbial profiles between ND cohorts and healthy controls, indicating a shared gut dysbiosis across diverse NDs. Studies investigating microbial taxa, metabolites, and signaling pathways have provided insights into the molecular mechanisms underlying gut microbiome-mediated effects on neurodegeneration. Elucidating the reciprocal interactions between the gut microbiome and the host physiology is essential for deciphering the GBA’s role in NDs. Despite advances, knowledge gaps remain. Longitudinal studies are required to monitor gut microbiome dynamics over ND progression. Mechanistic studies are needed to establish how gut microbiome composition affects disease. Methodological standardization for gut microbiome assessment is imperative for rigorous research. Future endeavors should aim to translate findings into clinical applications to exploit microbiome-based interventions for enhanced neurological outcomes in NDs.
Cited by 1
1 citation reported by external sources — individual citing-article records aren't available to list yet.
Related research
- Ritucharya, the Ayurvedic Seasonal Regimen, for Health Maintenance and Disease Prevention: A Critical Narrative Review of Classical Rationale and Contemporary Biological Evidence — shares topic coverage
- Study of the Gut Enterotypes in Egyptian Children with Autism Spectrum Disorder — shares topic coverage
- Role of Gut Microbiome on Metabolic Disorders — shares topic coverage
- The Role of Omics Technologies in Pet Food Science: Advancing Nutrition, Health, and Safety — shares topic coverage
- Therapeutic Potential of Rosemary: Bridging Traditional Uses and Modern Applications — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.